2016 International Congress Archives - Page 52 of 207

12:00pm-1:30pm: Utilization and longitudinal impact of anticholinergic use in Parkinson’s disease. National Parkinson Foundation (NPF) QII registry

V. Felix Saunders, K. Li, S. Luo, T. Simuni (Chicago, IL, USA)

Parkinson's disease: Clinical trials, pharmacology and treatment · Exhibit Hall located in Hall B, Level 2

12:00pm-1:30pm: Utilizing remote blood pressure monitoring in a phase III clinical drug trial for Parkinson’s disease

J.L. Adams, R.A. Biemiller, K.L. Andrzejewski, S. Sharma, R.L. Rockhill, B.L. Greco, K.C. Hodgeman, P. Singh, S. Khanuja, T. Simuni, K.M. Biglan (Rochester, NY, USA)

Clinical trials and therapy in movement disorders · Exhibit Hall located in Hall B, Level 2

12:00pm-1:30pm: Validation of a screening questionnaire for X-linked dystonia parkinsonism (XDP): The first phase of the population based prevalence study of XDP in Panay

J.D.B. Diestro, P.M.D. Pasco, L.V. Lee (Manila, Philippines)

Dystonia · Exhibit Hall located in Hall B, Level 2

12:00pm-1:30pm: Validation of the XDP-MDSP rating scale for the evaluation of patients with X-linked dystonia-parkinsonism (XDP)

P.D. Pasco, L.V. Lee, R.G. Jamora, C.E. Diesta, A.R. Ng, R.A. Teleg, C.L. Go, R.L. Rosales, H.H. Fernandez (Manila, Philippines)

Dystonia · Exhibit Hall located in Hall B, Level 2

12:00pm-1:30pm: Validity and reliability of the test d evaluation des membres superieurs de personnes agees (TEMPA) to assess upper limb in Parkinson’s disease

C.L. Correa, P.R. de-Freitas, A.E. Lemos, S.M. Michaelsen, A. Swarowsky (Rio de Janeiro, Brazil)

Parkinson's disease: Clinical trials, pharmacology and treatment · Exhibit Hall located in Hall B, Level 2

12:00pm-1:30pm: VANTAGE trial: Three year outcomes of a prospective, multi-center trial evaluating deep brain stimulation with a new multiple-source, constant-current rechargeable system in Parkinson’s disease

L. Timmerman, R. Jain, L. Chen, T. Brucke, F. Seijo, E. Suarez San Martin, C. Haegelen, M. Verin, V. Visser-Vandewalle, M.T. Barbe, S. Gill, A. Whone, M. Porta, D. Servello, F. Alesch (Cologne, Germany)

Parkinson's disease: Clinical trials, pharmacology and treatment · Exhibit Hall located in Hall B, Level 2

12:00pm-1:30pm: Video assessment of writer’s cramp

J.E. Park, B. Karp (Bethesda, MD, USA)

Dystonia · Exhibit Hall located in Hall B, Level 2

12:00pm-1:30pm: Virtual rehabilitation: A therapy for parkinsonism?

B.S. Zeigelboim, G.J.B. Santos, M.I.R. Severiano, H.A.G. Teive, A.B.M. Lacerda, C.M. Porto (Curitiba, Brazil)

Parkinson's disease: Clinical trials, pharmacology and treatment · Exhibit Hall located in Hall B, Level 2

12:00pm-1:30pm: Virtual-reality balance training with Nintendo-Wii games improves dynamic balance in Parkinson’s disease patients

G.H. Lee (Cheon-An, Korea)

Parkinson's disease: Clinical trials, pharmacology and treatment · Exhibit Hall located in Hall B, Level 2

12:00pm-1:30pm: Voice harmonic amplitude differences before and after LSVT LOUD^TM in Parkinson’s disease

M.P. Cannito, L.O. Ramig, A.E. Halpern, J.L. Spielman (Lafayette, LA, USA)

Parkinson's disease: Clinical trials, pharmacology and treatment · Exhibit Hall located in Hall B, Level 2